Isocitrate dehydrogenase mutations as potential tumour agnostic targets.

Macarulla T, Tabatabai G, Stacchiotti S, Bridgewater J

Open source

DOI
10.1016/j.ejcsup.2025.12.002
Published
2026 Mar
Container
EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.]
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejcsup.2025.12.002,
  title = {Isocitrate dehydrogenase mutations as potential tumour agnostic targets.},
  author = {Macarulla T and Tabatabai G and Stacchiotti S and Bridgewater J},
  year = {2026},
  journal = {EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.]},
  doi = {10.1016/j.ejcsup.2025.12.002},
  url = {https://doi.org/10.1016/j.ejcsup.2025.12.002}
}

RIS

TY  - JOUR
TI  - Isocitrate dehydrogenase mutations as potential tumour agnostic targets.
AU  - Macarulla T
AU  - Tabatabai G
AU  - Stacchiotti S
AU  - Bridgewater J
PY  - 2026
JO  - EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.]
DO  - 10.1016/j.ejcsup.2025.12.002
UR  - https://doi.org/10.1016/j.ejcsup.2025.12.002
ER  - 

APA

T, M., G, T., S, S., & J, B. (2026). Isocitrate dehydrogenase mutations as potential tumour agnostic targets.. EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.]. https://doi.org/10.1016/j.ejcsup.2025.12.002

Source records